AzTrials
AzTrials

Premature BirthIBAIPNCT04685356

Effect of the IBAIP in Preterm Infants Neurodevelopment

A study testing IBAIP : Infant Behaviour Assessment and Intervention Program, Standard Support and Ages and Stages Questionnaire (ASQ) in people with Premature Birth, run by University Hospital, Brest at 9 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Mortality in very preterm infants has decreased significantly over the past twenty years. However, neuromotor, behavioral and cognitive development disorders are more common in these children born before 33 weeks of gestation as compared to term born infants. Read more about this study

Who is it for?
Ages 25 to 32 weeks
Conditions the study is for
Premature Birth
What is being tested?
IBAIP : Infant Behaviour Assessment and Intervention Program, Standard Support and Ages and Stages Questionnaire (ASQ)
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
240 participants
Where
9 sitesFrance
Study dates
8 Nov 2022to 8 Jan 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 32 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Preterm infants born (including multiple pregnancies) at a gestational age between 25 weeks +0 days and 32 weeks + 6days.
  • Written informed consent of at least one of the parents / legal guardian or 2 parents / legal guardians depending on the family context
  • Normal neurological examination between 36 and 41 weeks of corrected age

Who cannot join

  • Intraventricular hemorrhage (III or IV), periventricular leukomalacia
  • Brain MRI abnormalities performed after 36 weeks of corrected age
  • Life-threatening pathology
  • Severe congenital abnomality
  • Severe maternal pathology (physical and / or mental)
  • Parents whose native language is not French
  • Participation in another interventional study on the management of post-hospital neurodevelopment disorders

Trial locations and contacts

9 sites in 1 country. Contact the study team or a site near you to ask about taking part.

9 sites in 1 country

France9 sites, 7 recruiting
  • CHU Angers

    Angers

    Bertrand LEBOUCHER, 2.41.35.44.07 ext. +33, BeLeboucher@chu-angers.fr

    Recruiting
  • CHU Besançon

    Besançon

    Emma BECUWE-GOSSELIN, 3.81.21.40.83 ext. +33, ebecuwe@chu-besancon.fr

    Recruiting
  • CHU Brest

    Brest, 29200

    Jean-Michel ROUE

    jean-michel.roue@chu-brest.fr

    Recruiting
  • CHU Caen

    Caen, 14033

    Valérie DATIN-DORRIERE, PhD, 2.31.27.25.64 ext. +33, datindorriere-v@chu-caen.fr

    Recruiting
  • CHU Grenoble

    Grenoble

    Blandine REBEILLE-BORGELLA, +33 4 76 76 55 77, brebeilleborgella@chu-grenoble.fr

    Recruiting
  • CHU Nantes

    Nantes, 44000

    Withdrawn
  • CHU Rennes

    Rennes

    Withdrawn
  • CHRU Strasbourg

    Strasbourg

    Pierre KUHN, 3.88.12.77.76 ext. +33, Pierre.Kuhn@chru-strasbourg.fr

    Recruiting
  • CHU Tours

    Tours, 37000

    Delphine MITANCHEZ, 2.47.47.92.48 ext. +33, delphine.mitanchez@univ-tours.fr

    Recruiting

Other trials in France

About this study

Official title: Effect of the Infant Behavioral Assessment and Intervention Program (IBAIP) in Preterm Infants on Neurodevelopment at 2 Years Corrected Age

Mortality in very preterm infants has decreased significantly over the past twenty years. However, neuromotor, behavioral and cognitive development disorders are more common in these children born before 33 weeks of gestation as compared to term born infants.

These neurodevelopmental disorders include difficulties with self-regulation, tone, posture or poor quality movements as well as inadequate responses to sensory simulation.

Read more

Post-hospital discharge follow-up and interventionsof children born very preterm ares very heterogeneous in France. They are mainly carried out in a rehabilitation center, based on caregivers whereas IBAIP is carried out at home and family centered.

Early interventions during hospitalization or after discharge appear potentially of great interest in improving the neurodevelopemental outcome of the very preterm infants. Several early interventions have been developed and evaluated in other countries. These interventions are designed to be used early in life, mainly during the first 3 years of life, and are based on brain plasticity and intense synaptogenesis during this period of life.

The IBAIP (Infant Behavior Assessment and Intervention Program) was developed on the same theoretical foundations as the NIDCAP (Neonatal Individualized Development Care and Assessment Program). IBAIP consists of providing the child and his family with an intervention, at home, starting just before hospital discharge up to a 6 months corrected age. .The aim of IBAIP is to support developmental functions including infant's self-regulation and focus on improving the responsiveness of parents' infant interactions.

Read the detailed description

This program consists of providing intervention, by a IBAIP trained and certified healthcare professional, with the child and his family, starting a few days before hospitalization discharge (hospital or home care) and continuing at home until the corrected age of 6 months. It focuses on the child's behaviors and consists of assisting the family in its interactions with the child so that these are adapted and responsive to the child's development needs over time through repeated interventions.

A cluster randomization will be used meaning the centers are randomized, not the individual patients. The centers will be randomized before the inclusion of patients in order to allow the physiotherapists or psychomotor therapists to be trained and certified to the IBAIP before the start of the trial.

Visit 1: Upon discharge from hospital, follow-up as part of standard care (control group) with at least 1 medical consultation per month during the first 6 months or according to the IBAIP program (experimental group) with one intervention before discharge from hospital and at home after hospital discharge, with1 session once a month up to 6 months corrected age (i.e. 6 to 8 sessions) in addition to standard care.

Visit 2: At 6 months corrected age, parents' response to the PSI (Parenting Stress Index) questionnaire.

Visit 3: At two years corrected age :

  • Assessment of the development quotient obtained on the BSID-IV scale during a consultation with a neuro-psychologist or pediatrician.
  • Parents' response to the PSI (Parenting Stress Index) questionnaire
  • Parents' response to the ASQ (Ages and Stages Questionnaire
Conditions
Premature Birth
Being tested
IBAIP : Infant Behaviour Assessment and Intervention Program, Standard Support, Ages and Stages Questionnaire (ASQ), Parenting Stress Index (PSI), Bayley Scales of Infant and Toddler Development (BSID-IV)
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IBAIP : Infant Behaviour Assessment and Intervention ProgramOther

    The IBAIP intervention program consists of providing an intervention with the child and their family, at home, upon discharge from hospital and up to a corrected age of 6 months. Interventions therefore take place at the early stage of the child's brain development. The intervention is performed by a IBAIP-trained and certified physiotherapist or psychomotor therapist trained , at the rate of one session per month over a period of approximately 6 to 8 months (6 months of corrected age). The session takes place in the child's usual living environment, at home, in the presence of at least one of the parents. It focuses on the child's behaviors and consists of assisting the family in its interactions with the child so that these are adapted and responsive to the child's development needs over time through repeated interventions.

  • Standard SupportOther

    One medical consultation per month and, if indicated by the physician providing follow-up, medical specialist and / or paramedical (physiotherapy, speech therapy, psychomotricity, etc.) consultations including interventions in the case of developmental delays

  • Ages and Stages Questionnaire (ASQ)Other

    Global development screening tool

  • Parenting Stress Index (PSI)Other

    Index used to detect difficulties sufficiently significant that they might require psychosocial intervention

  • Bayley Scales of Infant and Toddler Development (BSID-IV)Other

    This test was designed to measure the development of infants / young children. This assessment examines all spheres of child development, identifies children with developmental delay and assesses children's developmental performance compared to their peers.

Study groups in NCT04685356
Study groupRoleWhat they receive
IBAIP GroupExperimentalChildren benefiting from assessment and intervention providing by a healthcare professional (physiotherapist or psychomotor therapist) trained and certified for IBAIP. This care will take place upon discharge from the hospital at the rate of one session per month for 6 months. The sessions will take place in the presence of at least one of the parents and at home. These children will also benefit from standard follow-up (medical follow-up, paramedical or specialized medical support depending on the development and needs).
Receives: Other: IBAIP : Infant Behaviour Assessment and Intervention Program; Other: Ages and Stages Questionnaire (ASQ); Other: Parenting Stress Index (PSI); Other: Bayley Scales of Infant and Toddler Development (BSID-IV)
Control groupActive comparatorChildren benefiting from standard care upon discharge from hospital with 1 medical consultation per month and, medical sepcialist and / or paramedical(physiotherapy, speech therapy, psychomotricity, etc.). consultations if indicated by the physician providing follow-up
Receives: Other: Standard Support; Other: Ages and Stages Questionnaire (ASQ); Other: Parenting Stress Index (PSI); Other: Bayley Scales of Infant and Toddler Development (BSID-IV)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To assess the effect of the Infant Behavior Assessment and Intervention Program Program (IBAIP) in very preterm infants (< 33 weeks of gestation) on neurodevelopment at the corrected age of 2 years

    Patient neurodevelopment will be assessed using the Bayley Scales of Infant and Toddler Development (BSID-IV) scale. This test studies the different notions of development: cognitive, language, motor skills, socio-emotional, behavioral, communication and autonomy.

    Measured: 2 years of corrected age

Secondary outcomes (3)
  1. To assess the effect of IBAIP on the 5 sub-scores of BSID-IV: cognitive, language, motor, socio-emotional and behavioral adaptive

    The BSID-IV scale can be analyzed at the level of each of these subscales. The different scores obtained allow us to identify precisely at what level the effect on neurodevelopment was the most significant.

    Measured: 2 years of corrected age

  2. To assess the effect on the stress level of mothers and fathers

    To assess through the response to the Parental Stress Index. This questionnaire consists in 120 items using a 5-level Likert scale. It allows the assessment of life stress score, parental stress and child stress.

    Measured: 2 years of corrected age

  3. Parental assessment of psychomotor development

    Ages and Stages questionnaire completed by the parents to assess the child's neurodevelopment in 5 areas (fine motor skills, gross motor skills, communication, problem solving, individual or social skills).

    Measured: 2 years of corrected age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2020
  2. Study start8 Nov 2022
  3. Primary completion8 Jan 2028 (estimated)
  4. Study completion8 Jan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
240 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04685356
Sponsor's protocol ID
29BRC17.0219
Acronym
IBAIP
Status last verified
Jun 2026
First submitted
22 Dec 2020
Last updated
26 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data that underlie results in a publication

Publications

  • Smith M, Kuhn P, Thiriez G, Debillon T, Datin-Dorriere V, Leboucher B, Mitanchez D, Courtois-Communier E, Sizun J, Roue JM. Infant behavioural assessment and intervention program to support neurodevelopmental outcome of very preterm infants at two years corrected age: a cluster randomised controlled trial study protocol. BMJ Open. 2025 Sep 4;15(9):e088167. doi: 10.1136/bmjopen-2024-088167.

    PubMed 40908020

Questions about this trial

What is this clinical trial studying?

A study testing IBAIP : Infant Behaviour Assessment and Intervention Program, Standard Support and Ages and Stages Questionnaire (ASQ) in people with Premature Birth, run by University Hospital, Brest at 9 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jean-Michel ROUE, PhD (2.98.22.36.67 ext. +33, jean-michel.roue@chu-brest.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To assess the effect of the Infant Behavior Assessment and Intervention Program Program (IBAIP) in very preterm infants (< 33 weeks of gestation) on neurodevelopment at the corrected age of 2 years (time frame: 2 years of corrected age). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04685356, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in